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a b s t r a c t
The TyG index was evaluated as a surrogate method for estimation of insulin resistance (IR).
TyG index correlated with adiposity, metabolic and atherosclerosis markers related to IR
and presented a moderate degree of agreement with hyperglycemic clamp. TyG index
represents an accessible tool for assessment of IR in clinical practice.
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The assessment of insulin resistance (IR) is of interest because
of its key role in type 2 diabetes mellitus and metabolic
syndrome. The homeostatic model assessment (HOMA) is a
validated and widely used method to measure IR from fasting
glucose and insulin in epidemiological studies and has also
been used in clinical practice [1]. However, laboratory
determinations of plasma insulin are yet not available and
standardized in all services.
Recently, the TyG index, a product from the fasting levels of
triglycerides and glucose, presented promising results as
surrogate marker for the assessment of IR in Mexican patients
[2,3]. The spectrum of triglyceride and also IR levels is variable* Corresponding author at: LIMED, State University of Campinas, 420,
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  Open access under the Elsevier OA licenseaccording to ethnicity. So, validation is necessary to allow the
application of new indexes in different populations.
Given the continuing need for methods with accessibility
and with good discriminating power for the assessment of IR,
we evaluate the potential of using TyG index to assess IR in a
sample of Brazilian subjects, an admixture population, as well
TyG index correlation with adiposity, metabolic and subclini-
cal atherosclerosis markers related to IR.
2. Patients and methods
A cross-sectional study was conducted with 82 patients (84%
female). This study was approved by the Ethics Committee of Carlos Chagas st, Cidade Universita´ria ‘‘Zeferino Vaz’’, Zip Code:
18589.
s).
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Fig. 1 – Correlations between TyG index (A) and HOMA2-IR (B) with insulin resistance from the hyperglycemic clamp test.
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Campinas, Brazil.
Patients underwent an anthropometrical and a body
composition (bioelectrical impedance) assessment. Ultraso-
nography was applied to measure intra-abdominal visceral
and subcutaneous adipose tissue [4] and carotid intima-media
thickness [5]. The transthoracic echocardiogram measured
epicardial adipose tissue thickness on right ventricle [6].
Fasting plasma glucose, insulin, triglycerides, total choles-
terol and fractions, adiponectin and C-reactive protein (CRP)
were determined. HOMA2-IR [1] and TyG indexes [2,3] were
calculated. The 3-h hyperglycemic clamp test (180 mg/dl) was
the reference method for IR [7]. The mean glucose infusion
rate (GIRFFM) of the last clamp hour was adjusted for free fat
mass and represented the IR level of each subject [8].Table 1 – Correlations between TyG index and HOMA2-IR
with adiposity, metabolic and subclinical atherosclerosis
markers.
Parameters TyG index HOMA2-IR
Adiposity
Body mass index 0.47** 0.51**
Waist circumference 0.52** 0.52**
Sagittal abdominal diameter 0.59** 0.59**
Subcutaneous adipose tissue 0.14 0.11
Visceral adipose tissue 0.65** 0.49**
Epicardial adipose tissue 0.36* 0.31
Metabolic profile
Fasting insulin 0.54*** 0.98***
Total cholesterol 0.33** 0.03
LDL cholesterol 0.35** 0.01
HDL cholesterol 0.55** 0.39**
C reactive protein 0.35** 0.26*
Adiponectin 0.59** 0.43*
Subclinical atherosclerosis
Intima media thickness 0.35** 0.18
Spearman coefficient of correlation.
* p < 0.05.
** p < 0.01.
*** p < 0.001.Statistical analysis comprised Spearman’s correlation test,
inter-rater agreement weighted k test, and ROC analysis.
3. Results
A total of 82 subjects aged 22–81 (47.3  14.6) years participated
in this study. According to the ADA criteria, 33% were type 2
diabetic and 66% had normal glucose tolerance. In the BMI
assessment, 29.3% were normal weight, 25.6% overweight and
45.1% obese.
As demonstrated in Table 1, the TyG index was significant
correlated with several parameters of adiposity, metabolic and
subclinical atherosclerosis related to IR. In general, the
correlations for the TyG index were better compared with
the HOMA2-IR and it is noteworthy that the correlation found
for the GIR was stronger for the TyG index (Fig. 1).TyG index: AUC  = 0.79 (0.69-0.89 );  p<0.001  
HOMA2-IR: AUC  = 0.77 (0. 66-0.88 ); p<0.00 1 
Fig. 2 – Receiver operating characteristic (ROC) scatter plot
for TyG index in the identification of insulin resistance.
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between TyG index and the reference parameter (GIRFFM)
obtained from the hyperglycemic clamp test (weighted k
coefficient of agreement = 0.431; p < 0.001).
In the ROC analysis, the TyG showed a slightly better
performance in comparison with the HOMA2-IR in identifying
patients with IR (Fig. 2).
4. Discussion
The present study evaluated the performance of the TyG index
in the assessment of IR in a sample of Brazilian subjects in a
wide range of adiposity and glucose tolerance. This index has
the advantage of being applicable into clinical practice since
both triglyceride and glucose concentrations are inexpensive
and routinely measured.
Although the coefficient of agreement and the area under
the curve identified in the present study were not so elevated as
demonstrated in Mexican study already published [2,3], the TyG
index presented a slightly better performance in comparison
with the HOMA2-IR index. Furthermore, TyG index was
correlated with fat distribution and fat depots, metabolic
parameters and markers of subclinical atherosclerosis related
to IR. Hence, TyG index was significantly correlated to a first line
measurement of IR, i.e. hyperglycemic clamp.
5. Conclusions
The TyG index represents a useful and accessible tool for
assessment of IR in our Brazilian population.
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